Neurodegenerative diseases, such as Alzheimer's and Parkinson's, pose significant challenges to global public health, affecting cognitive processes and featuring a progressive decline of several brain functions. The search for effective interventions is ongoing, with recent focus turning towards the potential benefits of food supplements and nutraceuticals on cognitive functions and brain health due to their antioxidant, anti-inflammatory, and neuromodulatory properties. Emerging research suggests these dietary additions might influence the physiopathogenic processes underlying brain health, cognitive aging, and neurodegenerative diseases, potentially offering neuroprotection and symptom management. However, the diversity in compounds, varied mechanisms of action, and the inconsistency in clinical trials underline the complexity of their effectiveness.
This Research Topic seeks to highlight recent developments and existing knowledge in promoting brain health and cognitive processes with the use of food supplements and nutraceuticals in various human neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis (ALS), with a highlight on clinical implications, therapeutic possibilities, and molecular mechanisms. The nutraceuticals under consideration include polyphenols, omega-3 fatty acids, vitamins, minerals, and other bioactive compounds.
To gather further insights into the impact of food supplements and nutraceuticals on neurodegenerative diseases, we welcome submissions across a diverse range of manuscript types supported by the journal (including Brief Research Reports, Protocols, Review and Mini-Review, Original Research, etc.). These manuscripts should explore, but not be limited to, the following themes: - Cognitive and neurological functions targeted by nutraceuticals in neurodegenerative diseases - Efficacy and safety of nutraceuticals in people with neurodegenerative diseases - Direct and indirect effects of nutraceuticals on behavioral symptoms of neurodegenerative diseases - Comparative analyses of nutraceuticals versus or in add-on to pharmacological treatments - Long-term outcomes of dietary supplementation in managing symptoms of neurodegenerative diseases - Modification of disease progression by nutraceuticals supplementation - Policy implications and guidelines for the use of nutraceuticals in clinical practice - Mechanistic insights into how specific supplements affect neurodegenerative pathways
Articles accepted after peer review will be published and appear online as soon as approved for publication.
Register now to participate in this exciting Research Topic.
The Topic Editor George Perry is on the Scientific Advisory Board and holds shares in Synaptogenix Inc. The other Topic Editors report no competing interests related to this Research Topic.
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Case Report
Clinical Trial
Data Report
Editorial
FAIR² Data
General Commentary
Hypothesis and Theory
Methods
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Article types
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.